Reach Us +1-504-608-2390
R Joseph Olk | OMICS International
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

R Joseph Olk


Combination Therapy with Dietary Zeaxanthin for Neovascular Age Related Macular Degeneration. A Randomized Clinical Trial

Purpose: A previous comparative interventional study suggested oral zeaxanthin added to triple therapy of intravitreal bevacizumab, intravitreal corticosteroids and photodynamic therapy with verteporfin for the treatment of neovascular age-related macular degeneration (NVAMD) was comparatively effective and cost-effective. A randomized clinical tri... Read More»

R Joseph Olk, Enrique Peralta, Dennis L Gierhart, Melissa M Brown and Gary C Brown

Research Article: J Clin Exp Ophthalmol 2017, 8: 692

DOI: 10.4172/2155-9570.1000692

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article